About us
About Redenlab
Management team
Advisory board
Partners
What we do
Indications
Ataxia
Huntington’s Disease (HD)
Parkinson’s Disease
Alertness, Fatigue and Stress (AFS)
Frontotemporal Dementia (FTD)
Amyotrophic lateral sclerosis (ALS) / Motor Neurone Disease (MND)
Our technology
News & Publications
News
Events
Publications
Employment opportunities
Clinical Trial Solutions
Virtual trials
Redenlab’s recording solutions
Protocol design and development
Data analysis and interpretation
Quality control and assurance
Project management
Contact Us
Suite 669, 585 Little Collins Street
Melbourne VIC 3000 Australia
info@redenlab.com
Twitter
Linkedin
About us
About Redenlab
Management team
Advisory board
Partners
What we do
Indications
Ataxia
Huntington’s Disease (HD)
Parkinson’s Disease
Alertness, Fatigue and Stress (AFS)
Frontotemporal Dementia (FTD)
Amyotrophic lateral sclerosis (ALS) / Motor Neurone Disease (MND)
Our technology
News & Publications
News
Events
Publications
Employment opportunities
Clinical Trial Solutions
Virtual trials
Redenlab’s recording solutions
Protocol design and development
Data analysis and interpretation
Quality control and assurance
Project management
Contact Us
Partners
Ataxia UK
Bionics
Bost_Child_Hosp
CHOP
Curebase
Denali Therapeutics
ECDC
Universitat Tubingen
FA
Fara
Gen_Stut
Griffith
Harvard
Jaguar Gene Therapy
Larimar
MIT
Mitsubishi Tanabe Pharma Ameria
Monash
Murdoch
Novartis
PTC
QIMR Berghofer Medical Research Institute
Radboud
Retrotope
Roche
MelbHosp
HospitalSantJoandeDéu
Simons Foundation
Takeda
Track-FA
UCSF
The University of Auckland, Auckland District Health Board
University of Florida
MelbUni
Uni_Rhode
Uni_SA
University of Strathclyde Glasgow
Texas
UniTubingen
WEHI
Wesley
×
×
